Popma JJ, Tulli M. Spirit First – Another hurdle is cleared. EuroIntervention. 2005 Nov;1(3):260-3.
Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Bonan R, Popma JJ, Cutlip DE, Fitzgerald P, Prpic R, Kuntz RE. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial. EuroIntervention. 2005 Aug;1(2):157-64.
Cannon CP. Update to International Classification of Diseases, 9th Revision codes: distinguishes STEMI from NSTEMI. Crit Pathw Cardiol. 2005 Dec;4(4):185-6. doi: 10.1097/01.hpc.0000185739.52581.92.
Steinberg BA, Braganza AJ, Eminowicz G, Dibattiste PM, Flaker GC, Murphy SA, Cannon CP. Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18. Crit Pathw Cardiol. 2005 Dec;4(4):169-73. doi: 10.1097/01.hpc.0000188384.64039.8f.
Cannon CP. Implementation of critical pathways in the “real world”. Crit Pathw Cardiol. 2005 Jun;4(2):110-4. doi: 10.1097/01.hpc.0000164657.30984.47.
Morrow DA, Cannon CP. Brigham and Women’s Hospital admission order set for unstable angina/non-ST elevation myocardial infarction. Crit Pathw Cardiol. 2005 Jun;4(2):107-9. doi: 10.1097/01.hpc.0000167248.42627.6a.
Gurjeva OS, Roe MT, Murphy SA, Moliterno DJ, Cannon CP; GUARANTEE investigators. Unfortunate impact of age on the management and outcomes of unstable angina and non-ST elevation myocardial infarction (The GUARANTEE Registry). Crit Pathw Cardiol. 2005 Jun;4(2):81-7. doi: 10.1097/01.hpc.0000164658.06135.a2.
Cannon CP. What is the optimal timing of clopidogrel in acute coronary syndromes?. Crit Pathw Cardiol. 2005 Mar;4(1):46-50. doi: 10.1097/01.hpc.0000155972.10085.27.
Ray KK, Cannon CP. Time to benefit: an emerging concept for assessing the efficacy of statin therapy in cardiovascular disease. Crit Pathw Cardiol. 2005 Mar;4(1):43-5. doi: 10.1097/01.hpc.0000154979.98731.5d.
Lader EW, Cannon CP. How to join a clinical trial. Crit Pathw Cardiol. 2005 Mar;4(1):26-9. doi: 10.1097/01.hpc.0000153394.65699.23.
Januzzi JL. Making the right choice. Newsweek. 2005 Oct 3;146(14):68.
O’Brien MC, Champion H, D’Agostino RB, Martin BA, McCoy TP, Wolfson M, Durant RH. How ready are colleges for an environmental approach that utilizes campus/community coalitions?. Int Q Community Health Educ. 2005-2006;25(3):295-305. doi: 10.2190/G542-W332-GG21-056U.
Turchin A, Pendergrass ML, Kohane IS. DITTO – a tool for identification of patient cohorts from the text of physician notes in the electronic medical record. AMIA Annu Symp Proc. 2005;2005:744-8.
Cannon CP. The endocannabinoid system: a new approach to control cardiovascular disease. Clin Cornerstone. 2005;7(2-3):17-26. doi: 10.1016/s1098-3597(05)80064-x.
Murabito JM, Pencina MJ, Nam BH, D’Agostino RB Sr, Wang TJ, Lloyd-Jones D, Wilson PW, O’Donnell CJ. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA. 2005 Dec 28;294(24):3117-23. doi: 10.1001/jama.294.24.3117.
Alexander KP, Chen AY, Roe MT, Newby LK, Gibson CM, Allen-LaPointe NM, Pollack C, Gibler WB, Ohman EM, Peterson ED; CRUSADE Investigators. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA. 2005 Dec 28;294(24):3108-16. doi: 10.1001/jama.294.24.3108.
Mukherjee D, Evangelista A, Nienaber CA, Sechtem U, Suzuki T, Trimarchi S, Llovet A, Myrmel T, O’Gara PT, Fang J, Cooper JV, Oh JK, Januzzi JL, Hutchison S, Fattori R, Pape LA, Isselbacher EM, Eagle KA. Implications of periaortic hematoma in patients with acute aortic dissection (from the International Registry of Acute Aortic Dissection). Am J Cardiol. 2005 Dec 15;96(12):1734-8. doi: 10.1016/j.amjcard.2005.07.098. Epub 2005 Nov 2.
Wilson PW, Nam BH, Pencina M, D’Agostino RB Sr, Benjamin EJ, O’Donnell CJ. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med. 2005 Nov 28;165(21):2473-8. doi: 10.1001/archinte.165.21.2473.
Doros G, Geier AB. Probability of replication revisited: comment on “An alternative to Null-Hypothesis Significance Tests.”. Psychol Sci. 2005 Dec;16(12):1005-6. doi: 10.1111/j.1467-9280.2005.01651.x.
Pinto DS, Kirtane AJ, Ruocco NA, Deibele AJ, Shui A, Buros J, Murphy SA, Gibson CM. Administration of intracoronary eptifibatide during ST-elevation myocardial infarction. Am J Cardiol. 2005 Dec 1;96(11):1494-7. doi: 10.1016/j.amjcard.2005.07.056. Epub 2005 Oct 17.
Yeh RW, Triadafilopoulos G. Submucosal injection: safety cushion at what cost?. Gastrointest Endosc. 2005 Dec;62(6):943-5. doi: 10.1016/j.gie.2005.07.041.
Sabatine MS, Morrow DA, Montalescot G, Dellborg M, Leiva-Pons JL, Keltai M, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald E; Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation. 2005 Dec 20;112(25):3846-54. doi: 10.1161/CIRCULATIONAHA.105.595397. Epub 2005 Nov 15.
Ly HQ, Denault A, Dupuis J, Vadeboncoeur A, Harel F, Arsenault A, Gibson CM, Bonan R. A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study). Am Heart J. 2005 Nov;150(5):933. doi: 10.1016/j.ahj.2005.02.049.
Cannon CP. The IDEAL cholesterol: lower is better. JAMA. 2005 Nov 16;294(19):2492-4. doi: 10.1001/jama.294.19.2492.
Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Koglin J, Russell ME; TAXUS VI Investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation. 2005 Nov 22;112(21):3306-13. doi: 10.1161/CIRCULATIONAHA.105.552190. Epub 2005 Nov 14.
Leon MB, Kornowski R, Downey WE, Weisz G, Baim DS, Bonow RO, Hendel RC, Cohen DJ, Gervino E, Laham R, Lembo NJ, Moses JW, Kuntz RE. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol. 2005 Nov 15;46(10):1812-9. doi: 10.1016/j.jacc.2005.06.079. Epub 2005 Oct 19.
Levetan CS, Dawn KR, Murray JF, Popma JJ, Ratner RE, Robbins DC. Impact of computer-generated personalized goals on cholesterol lowering. Value Health. 2005 Nov-Dec;8(6):639-46. doi: 10.1111/j.1524-4733.2005.00057.x.
Polomoscanik SC, Cannon CP, Neenan TX, Holmes-Farley SR, Mandeville WH, Dhal PK. Hydroxamic acid-containing hydrogels for nonabsorbed iron chelation therapy: synthesis, characterization, and biological evaluation. Biomacromolecules. 2005 Nov-Dec;6(6):2946-53. doi: 10.1021/bm050036p.
Cannon CP. Acute coronary syndromes: risk stratification and initial management. Cardiol Clin. 2005 Nov;23(4):401-9, v. doi: 10.1016/j.ccl.2005.08.006.
Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005 Nov 15;112(20):3066-72. doi: 10.1161/CIRCULATIONAHA.105.539528. Epub 2005 Nov 7.
Ryan JW, Peterson ED, Chen AY, Roe MT, Ohman EM, Cannon CP, Berger PB, Saucedo JF, DeLong ER, Normand SL, Pollack CV Jr, Cohen DJ; CRUSADE Investigators. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry. Circulation. 2005 Nov 15;112(20):3049-57. doi: 10.1161/CIRCULATIONAHA.105.582346. Epub 2005 Nov 7.
Kaneda H, Ako J, Honda Y, Terashima M, Morino Y, Yock PG, Popma JJ, Leon MB, Moses JW, Fitzgerald PJ. Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation. Am J Cardiol. 2005 Nov 15;96(10):1404-7. doi: 10.1016/j.amjcard.2005.07.044. Epub 2005 Sep 29.
Terry DF, Pencina MJ, Vasan RS, Murabito JM, Wolf PA, Hayes MK, Levy D, D’Agostino RB, Benjamin EJ. Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J Am Geriatr Soc. 2005 Nov;53(11):1944-50. doi: 10.1111/j.1532-5415.2005.00465.x.
Peter I, Shearman AM, Zucker DR, Schmid CH, Demissie S, Cupples LA, Larson MG, Vasan RS, D’Agostino RB, Karas RH, Mendelsohn ME, Housman DE, Levy D. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens. 2005 Dec;23(12):2193-200. doi: 10.1097/01.hjh.0000188728.66183.92.
Mukamal KJ, Massaro JM, Ault KA, Mittleman MA, Sutherland PA, Lipinska I, Levy D, D’Agostino RB, Tofler GH. Alcohol consumption and platelet activation and aggregation among women and men: the Framingham Offspring Study. Alcohol Clin Exp Res. 2005 Oct;29(10):1906-12. doi: 10.1097/01.alc.0000183011.86768.61.
Kaplan AV, Harvey ED, Kuntz RE, Shiran H, Robb JF, Fitzgerald P. Humanitarian Use Devices/Humanitarian Device Exemptions in cardiovascular medicine. Circulation. 2005 Nov 1;112(18):2883-6. doi: 10.1161/CIRCULATIONAHA.105.553701.
Mauri L, Orav EJ, Candia SC, Cutlip DE, Kuntz RE. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation. 2005 Nov 1;112(18):2833-9. doi: 10.1161/CIRCULATIONAHA105.570093.
Millen BE, Quatromoni PA, Pencina M, Kimokoti R, Nam BH, Cobain S, Kozak W, Appugliese DP, Ordovas J, D’Agostino RB. Unique dietary patterns and chronic disease risk profiles of adult men: the Framingham nutrition studies. J Am Diet Assoc. 2005 Nov;105(11):1723-34. doi: 10.1016/j.jada.2005.08.007.
Tofler GH, Massaro J, Levy D, Mittleman M, Sutherland P, Lipinska I, Muller JE, D’Agostino RB. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). Am J Cardiol. 2005 Nov 1;96(9):1280-3. doi: 10.1016/j.amjcard.2005.06.072. Epub 2005 Sep 8.
Sakurai R, Ako J, Morino Y, Sonoda S, Kaneda H, Terashima M, Hassan AH, Leon MB, Moses JW, Popma JJ, Bonneau HN, Yock PG, Fitzgerald PJ, Honda Y; SIRIUS Trial Investigators. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol. 2005 Nov 1;96(9):1251-3. doi: 10.1016/j.amjcard.2005.06.066. Epub 2005 Sep 6.
Moussa I, Ellis SG, Jones M, Kereiakes DJ, McMartin D, Rutherford B, Mehran R, Collins M, Leon MB, Popma JJ, Russell ME, Stone GW. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). Am J Cardiol. 2005 Nov 1;96(9):1242-7. doi: 10.1016/j.amjcard.2005.06.064. Epub 2005 Sep 15.
Shavelle DM, Rasouli ML, Frederick P, Gibson CM, French WJ; National Registry of Myocardial Infarction Investigators. Outcome in patients transferred for percutaneous coronary intervention (a national registry of myocardial infarction 2/3/4 analysis). Am J Cardiol. 2005 Nov 1;96(9):1227-32. doi: 10.1016/j.amjcard.2005.06.061. Epub 2005 Sep 2.
Dupuis J, Tardif JC, Rouleau JL, Ricci J, Arnold M, Lonn E, Roux R, Title LM, Amyot R, Bonafede N, Woo A, Cannon CP. Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial). Am J Cardiol. 2005 Nov 1;96(9):1207-13. doi: 10.1016/j.amjcard.2005.06.057. Epub 2005 Sep 6.
Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005 Nov;54(11):3252-7. doi: 10.2337/diabetes.54.11.3252.
Ray KK, Cannon CP. Optimal goals for statin use in patients with coronary artery disease. Curr Opin Cardiol. 2005 Nov;20(6):525-9. doi: 10.1097/01.hco.0000184529.52832.e6.
Stone GW, Reifart NJ, Moussa I, Hoye A, Cox DA, Colombo A, Baim DS, Teirstein PS, Strauss BH, Selmon M, Mintz GS, Katoh O, Mitsudo K, Suzuki T, Tamai H, Grube E, Cannon LA, Kandzari DE, Reisman M, Schwartz RS, Bailey S, Dangas G, Mehran R, Abizaid A, Moses JW, Leon MB, Serruys PW. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation. 2005 Oct 18;112(16):2530-7. doi: 10.1161/CIRCULATIONAHA.105.583716.
Reynolds MR, Berry RW, Binder LI. Site-specific nitration differentially influences tau assembly in vitro. Biochemistry. 2005 Oct 25;44(42):13997-4009. doi: 10.1021/bi051028w.
Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol. 2005 Oct 18;46(8):1425-33. doi: 10.1016/j.jacc.2005.05.086.
Ray KK, Cannon CP, Cairns R, Morrow DA, Rifai N, Kirtane AJ, McCabe CH, Skene AM, Gibson CM, Ridker PM, Braunwald E; PROVE IT-TIMI 22 Investigators. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005 Oct 18;46(8):1417-24. doi: 10.1016/j.jacc.2005.08.024.
Wiviott SD, Cannon CP, Morrow DA, Ray KK, Pfeffer MA, Braunwald E; PROVE IT-TIMI 22 Investigators. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol. 2005 Oct 18;46(8):1411-6. doi: 10.1016/j.jacc.2005.04.064.
Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E; PROVE IT-TIMI 22 Investigators. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005 Oct 18;46(8):1405-10. doi: 10.1016/j.jacc.2005.03.077.
Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB. Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging. 2005 Dec;26 Suppl 1:11-6. doi: 10.1016/j.neurobiolaging.2005.08.019. Epub 2005 Oct 11.
Murphy TP, Cooper CJ, Dworkin LD, Henrich WL, Rundback JH, Matsumoto AH, Jamerson KA, D’Agostino RB. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol. 2005 Oct;16(10):1295-300. doi: 10.1097/01.RVI.0000176301.69756.28.
Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D’Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005 Oct 12;294(14):1799-809. doi: 10.1001/jama.294.14.1799.
Stone GW, Kandzari DE, Mehran R, Colombo A, Schwartz RS, Bailey S, Moussa I, Teirstein PS, Dangas G, Baim DS, Selmon M, Strauss BH, Tamai H, Suzuki T, Mitsudo K, Katoh O, Cox DA, Hoye A, Mintz GS, Grube E, Cannon LA, Reifart NJ, Reisman M, Abizaid A, Moses JW, Leon MB, Serruys PW. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation. 2005 Oct 11;112(15):2364-72. doi: 10.1161/CIRCULATIONAHA.104.481283.
Bainey KR, Senaratne MP. Is the outcomes of early ST-segment resolution after thrombolytic therapy in acute myocardial infarction always favorable?. J Electrocardiol. 2005 Oct;38(4):354-60. doi: 10.1016/j.jelectrocard.2005.03.015. Epub 2005 Jun 23.
Ouriel K, Wholey MH, Fayad P, Katzen BT, Whitlow P, Frentzko M, Kuntz RE, Wechsler L, Hopkins N, Satler L, Mishkel G, Yadav JS. Feasibility trial of carotid stenting with and without an embolus protection device. J Endovasc Ther. 2005 Oct;12(5):525-37. doi: 10.1583/05-1573.1.
Rana JS, Mittleman MA, Ho KK, Cutlip DE. Obesity and clinical restenosis after coronary stent placement. Am Heart J. 2005 Oct;150(4):821-6. doi: 10.1016/j.ahj.2004.11.022.
Alexander JH, Ferguson TB Jr, Joseph DM, Mack MJ, Wolf RK, Gibson CM, Gennevois D, Lorenz TJ, Harrington RA, Peterson ED, Lee KL, Califf RM, Kouchoukos NT; PREVENT IV Investigators. The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. Am Heart J. 2005 Oct;150(4):643-9. doi: 10.1016/j.ahj.2005.05.021.
Kwok OH, Chow WH, Law TC, Chiu A, Ng W, Lam WF, Hong MK, Popma JJ. First human experience with angiopeptin-eluting stent: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Catheter Cardiovasc Interv. 2005 Dec;66(4):541-6. doi: 10.1002/ccd.20558.
Eaker ED, Sullivan LM, Kelly-Hayes M, D’Agostino RB Sr, Benjamin EJ. Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom Med. 2005 Sep-Oct;67(5):692-6. doi: 10.1097/01.psy.0000174050.87193.96.
Vasan RS, Pencina MJ, Cobain M, Freiberg MS, D’Agostino RB. Estimated risks for developing obesity in the Framingham Heart Study. Ann Intern Med. 2005 Oct 4;143(7):473-80. doi: 10.7326/0003-4819-143-7-200510040-00005.
Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D’Agostino RB, Stroup TS, Davis S, Lieberman JA. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005 Dec 1;80(1):45-53. doi: 10.1016/j.schres.2005.08.010. Epub 2005 Sep 28.
Kruse RL, Mehr DR, van der Steen JT, Ooms ME, Madsen RW, Sherman AK, D’Agostino RB, van der Wal G, Ribbe MW. Antibiotic treatment and survival of nursing home patients with lower respiratory tract infection: a cross-national analysis. Ann Fam Med. 2005 Sep-Oct;3(5):422-9. doi: 10.1370/afm.389.
Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O’Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME; TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005 Sep 14;294(10):1215-23. doi: 10.1001/jama.294.10.1215.
Arnlöv J, Pencina MJ, Nam BH, Meigs JB, Fox CS, Levy D, D’Agostino RB, Vasan RS. Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation. 2005 Sep 20;112(12):1719-27. doi: 10.1161/CIRCULATIONAHA.105.535039. Epub 2005 Sep 12.
Stone GW, Colombo A, Teirstein PS, Moses JW, Leon MB, Reifart NJ, Mintz GS, Hoye A, Cox DA, Baim DS, Strauss BH, Selmon M, Moussa I, Suzuki T, Tamai H, Katoh O, Mitsudo K, Grube E, Cannon LA, Kandzari DE, Reisman M, Schwartz RS, Bailey S, Dangas G, Mehran R, Abizaid A, Serruys PW. Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results. Catheter Cardiovasc Interv. 2005 Oct;66(2):217-36. doi: 10.1002/ccd.20489.
Levine GN, Lincoff AM, Ferguson JJ 3rd, Mahaffey KW, Goodman SG, Cannon CP, Theroux P, Fox KA. Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade. Catheter Cardiovasc Interv. 2005 Oct;66(2):149-57. doi: 10.1002/ccd.20469.
Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Lewis BS, Murphy SA, McCabe CH, Braunwald E; Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA. 2005 Sep 14;294(10):1224-32. doi: 10.1001/jama.294.10.1224. Epub 2005 Sep 4.
Pinto DS, Blair BM, Schwartzstein RM, Smith CC. Clinical problem-solving. A sailor’s heartbreak. N Engl J Med. 2005 Sep 1;353(9):934-9. doi: 10.1056/NEJMcps044239.
Ray KK, Cannon CP. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?. Am J Cardiol. 2005 Sep 5;96(5A):54F-60F. doi: 10.1016/j.amjcard.2005.06.027.
Moghbeli N, Kirtane AJ, Ray KK, Murphy SA, Gibson CM, Braunwald E, Cannon CP; TIMI Study Group. C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial). Am J Cardiol. 2005 Sep 1;96(5):635-8. doi: 10.1016/j.amjcard.2005.04.033.
Kuntz RE, Normand SL. Measuring percutaneous coronary intervention quality by simple case volume. Circulation. 2005 Aug 23;112(8):1088-91. doi: 10.1161/CIRCULATIONAHA.105.561126.
Elias MF, Sullivan LM, D’Agostino RB, Elias PK, Jacques PF, Selhub J, Seshadri S, Au R, Beiser A, Wolf PA. Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am J Epidemiol. 2005 Oct 1;162(7):644-53. doi: 10.1093/aje/kwi259. Epub 2005 Aug 17.
Pickett CC, Zimetbaum PJ. Palpitations: a proper evaluation and approach to effective medical therapy. Curr Cardiol Rep. 2005 Sep;7(5):362-7. doi: 10.1007/s11886-005-0090-7.
Yeh RW, Triadafilopoulos G. Endoscopic antireflux therapy: the Stretta procedure. Thorac Surg Clin. 2005 Aug;15(3):395-403. doi: 10.1016/j.thorsurg.2005.03.006.
Januzzi JL, Eagle KA, Cooper JV, Fang J, Sechtem U, Myrmel T, Evangelista A, Oh JK, Llovet A, O’Gara PT, Nienaber CA, Isselbacher EM. Acute aortic dissection presenting with congestive heart failure: results from the International Registry of Acute Aortic Dissection. J Am Coll Cardiol. 2005 Aug 16;46(4):733-5. doi: 10.1016/j.jacc.2005.05.023.
Zimetbaum PJ, Josephson ME. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med. 2005 Aug 11;353(6):627-30; author reply 627-30.
Cutlip DE, Kuntz RE. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes. Circulation. 2005 Aug 9;112(6):916-22; discussion 922.
Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D’Agostino RB, Vasan RS. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005 Aug 16;112(7):969-75. doi: 10.1161/CIRCULATIONAHA.105.538132. Epub 2005 Aug 8.
Ohman EM, Van de Werf F, Antman EM, Califf RM, de Lemos JA, Gibson CM, Oliverio RL, Harrelson L, McCabe C, DiBattiste P, Braunwald E; FASTER (TIMI 24) Investigators. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial. Am Heart J. 2005 Jul;150(1):79-88. doi: 10.1016/j.ahj.2005.01.007.
Kuntz RE, Rogers C, Baim DS. Percutaneous coronary intervention-induced emboli during primary PCI for STEMI: too little, too much, or too late?. Am Heart J. 2005 Jul;150(1):4-6. doi: 10.1016/j.ahj.2005.02.017.
Murabito JM, Evans JC, D’Agostino RB Sr, Wilson PW, Kannel WB. Temporal trends in the incidence of intermittent claudication from 1950 to 1999. Am J Epidemiol. 2005 Sep 1;162(5):430-7. doi: 10.1093/aje/kwi217. Epub 2005 Aug 2.
Piacentini G, Digilio MC, Capolino R, Zorzi AD, Toscano A, Sarkozy A, D’Agostino R, Marasini M, Russo MG, Dallapiccola B, Marino B. Familial recurrence of heart defects in subjects with congenitally corrected transposition of the great arteries. Am J Med Genet A. 2005 Aug 30;137(2):176-80. doi: 10.1002/ajmg.a.30859.
Gibler WB, Cannon CP, Blomkalns AL, Char DM, Drew BJ, Hollander JE, Jaffe AS, Jesse RL, Newby LK, Ohman EM, Peterson ED, Pollack CV; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing; Quality of Care and Outcomes Research Interdisciplinary Working Group; Society of Chest Pain Centers. Practical implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the emergency department. Ann Emerg Med. 2005 Aug;46(2):185-97. doi: 10.1016/j.annemergmed.2005.04.022.
Young LH, Li J, Baron SJ, Russell RR. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med. 2005 Apr;15(3):110-8. doi: 10.1016/j.tcm.2005.04.005.
Cannon CP, Mehta SR, Aranki SF. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery. Ann Thorac Surg. 2005 Aug;80(2):768-79. doi: 10.1016/j.athoracsur.2004.09.058.
Barbucci R, Torricelli P, Fini M, Pasqui D, Favia P, Sardella E, d’Agostino R, Giardino R. Proliferative and re-defferentiative effects of photo-immobilized micro-patterned hyaluronan surfaces on chondrocyte cells. Biomaterials. 2005 Dec;26(36):7596-605. doi: 10.1016/j.biomaterials.2005.05.090.
Sakhuja R, Chen AA, Anwaruddin S, Baggish AL, Januzzi JL Jr. Combined use of amino terminal-pro-brain natriuretic peptide levels and QRS duration to predict left ventricular systolic dysfunction in patients with dyspnea. Am J Cardiol. 2005 Jul 15;96(2):263-6. doi: 10.1016/j.amjcard.2005.03.056.
Djoussé L, Levy D, Herbert AG, Wilson PW, D’Agostino RB, Cupples LA, Karamohamed S, Ellison RC. Influence of alcohol dehydrogenase 1C polymorphism on the alcohol-cardiovascular disease association (from the Framingham Offspring Study). Am J Cardiol. 2005 Jul 15;96(2):227-32. doi: 10.1016/j.amjcard.2005.03.050.
Cannon CP, Murphy SA, Braunwald E. Intensive lipid lowering with atorvastatin in coronary disease. N Engl J Med. 2005 Jul 7;353(1):93-6; author reply 93-6.
Millen BE, Quatromoni PA, Nam BH, Pencina MJ, Polak JF, Kimokoti RW, Ordovas JM, D’Agostino RB. Compliance with expert population-based dietary guidelines and lower odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. Am J Clin Nutr. 2005 Jul;82(1):174-80. doi: 10.1093/ajcn.82.1.174.
Reynolds MR, Rakasz E, Skinner PJ, White C, Abel K, Ma ZM, Compton L, Napoé G, Wilson N, Miller CJ, Haase A, Watkins DI. CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J Virol. 2005 Jul;79(14):9228-35. doi: 10.1128/JVI.79.14.9228-9235.2005.
Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, Cannon CP, Braunwald E, Gibson CM; TIMI Study Group. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005 Jul 5;46(1):178-80. doi: 10.1016/j.jacc.2005.03.052.
Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J. 2005 Apr;149(4):744-50. doi: 10.1016/j.ahj.2004.07.010.
Silber S, Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Bass T, O’Neill W, Lasala J, Reisman M, Sharma SK, Kuntz RE, Bonan R; START Investigators. Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis. Am Heart J. 2005 Apr;149(4):689-94. doi: 10.1016/j.ahj.2004.05.061.
Gomberg-Maitland M, Murphy SA, Moliterno DJ, Cannon CP. Are we appropriately triaging patients with unstable angina?. Am Heart J. 2005 Apr;149(4):613-8. doi: 10.1016/j.ahj.2004.09.035.
Yeh RW, Triadafilopoulos G. Endoscopic therapy for Barrett’s esophagus. Gastrointest Endosc Clin N Am. 2005 Jul;15(3):377-97, vii. doi: 10.1016/j.giec.2005.04.004.
Turchin A, Kohane IS, Pendergrass ML. Identification of patients with diabetes from the text of physician notes in the electronic medical record. Diabetes Care. 2005 Jul;28(7):1794-5. doi: 10.2337/diacare.28.7.1794.
Giugliano RP, Newby LK, Harrington RA, Gibson CM, Van de Werf F, Armstrong P, Montalescot G, Gilbert J, Strony JT, Califf RM, Braunwald E; EARLY ACS Steering Committee. The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome–study design and rationale. Am Heart J. 2005 Jun;149(6):994-1002. doi: 10.1016/j.ahj.2005.03.029.
Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005 Jun 28;111(25):3435-42. doi: 10.1161/CIRCULATIONAHA.104.513952. Epub 2005 Jun 20.
Radziszewska B, Hart RG, Wolf PA, D’Agostino RB Sr, Cutler JA. Clinical research in primary stroke prevention: needs, opportunities, and challenges. Neuroepidemiology. 2005;25(2):91-104. doi: 10.1159/000086342. Epub 2005 Jun 13.
Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005 Jun 15;293(23):2908-17. doi: 10.1001/jama.293.23.2908.
Moore LL, Visioni AJ, Qureshi MM, Bradlee ML, Ellison RC, D’Agostino R. Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. Arch Intern Med. 2005 Jun 13;165(11):1298-303. doi: 10.1001/archinte.165.11.1298.
Ray KK, Cannon CP. Atorvastatin and cardiovascular protection: a review and comparison of recent clinical trials. Expert Opin Pharmacother. 2005 Jun;6(6):915-27. doi: 10.1517/14656566.6.6.915.
O’Donoghue M, Chen A, Baggish AL, Anwaruddin S, Krauser DG, Tung R, Januzzi JL. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail. 2005 Jun;11(5 Suppl):S9-14. doi: 10.1016/j.cardfail.2005.04.011.
Hanley AJ, Meigs JB, Williams K, Haffner SM, D’Agostino RB Sr. Re: “(Mis)use of factor analysis in the study of insulin resistance syndrome”. Am J Epidemiol. 2005 Jun 15;161(12):1182-4. doi: 10.1093/aje/kwi153.
Reid IR, Tonkin A, Cannon CP. Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial–secondary analysis of a randomized controlled trial. Bone. 2005 Aug;37(2):190-1. doi: 10.1016/j.bone.2005.04.012.
Kirtane AJ, Leder DM, Waikar SS, Chertow GM, Ray KK, Pinto DS, Karmpaliotis D, Burger AJ, Murphy SA, Cannon CP, Braunwald E, Gibson CM; TIMI Study Group. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J Am Coll Cardiol. 2005 Jun 7;45(11):1781-6. doi: 10.1016/j.jacc.2005.02.068.
Scirica BM, Cannon CP. Treatment of elevated cholesterol. Circulation. 2005 May 31;111(21):e360-3. doi: 10.1161/CIRCULATIONAHA.105.539106.
Chang A, Gibson CM. Current Assessments of the Adequacy of Myocardial Perfusion During Acute MI. Curr Treat Options Cardiovasc Med. 2005 May;7(1):25-34. doi: 10.1007/s11936-005-0003-5.
Gibler WB, Cannon CP, Blomkalns AL, Char DM, Drew BJ, Hollander JE, Jaffe AS, Jesse RL, Newby LK, Ohman EM, Peterson ED, Pollack CV; American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care); Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group; Society of Chest Pain Centers. Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers. Circulation. 2005 May 24;111(20):2699-710. doi: 10.1161/01.CIR.0000165556.44271.BE.
Mega JL, Morrow DA, Sabatine MS, Zhao XQ, Snapinn SM, DiBattiste PM, Gibson CM, Antman EM, Braunwald E, Théroux P. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial. Am Heart J. 2005 May;149(5):846-50. doi: 10.1016/j.ahj.2004.08.042.
Ridker PM, Morrow DA, Rose LM, Rifai N, Cannon CP, Braunwald E. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial. J Am Coll Cardiol. 2005 May 17;45(10):1644-8. doi: 10.1016/j.jacc.2005.02.080. Epub 2005 Apr 25.
O’Donoghue M, Januzzi JL Jr. N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure. Expert Rev Cardiovasc Ther. 2005 May;3(3):487-96. doi: 10.1586/14779072.3.3.487.
Laham RJ, Post M, Rezaee M, Donnell-Fink L, Wykrzykowska JJ, Lee SU, Baim DS, Sellke FW. Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution. Drug Metab Dispos. 2005 Aug;33(8):1101-7. doi: 10.1124/dmd.104.002774. Epub 2005 May 6.
Mauri L, O’Malley AJ, Popma JJ, Moses JW, Leon MB, Holmes DR Jr, Teirstein PS, Cutlip DE, Donahoe D, Kuntz RE. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2005 May 15;95(10):1140-5. doi: 10.1016/j.amjcard.2005.01.039.
Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med. 2005 May 3;142(9):786-91. doi: 10.7326/0003-4819-142-9-200505030-00015.
Smith CS, Cannon CP, McCabe CH, Murphy SA, Bentley J, Braunwald E. Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial. Am Heart J. 2005 Mar;149(3):444-50. doi: 10.1016/j.ahj.2004.06.033.
Muni NI, Califf RM, Foy JR, Boam AB, Zuckerman BD, Kuntz RE. Coronary drug-eluting stent development: issues in trial design. Am Heart J. 2005 Mar;149(3):415-33. doi: 10.1016/j.ahj.2004.09.001.
Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, Mügge A, Di Pede F, Füllgraf D, Aengevaeren W, Spedicato L, Popma JJ. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation. 2005 Apr 26;111(16):2107-11. doi: 10.1161/01.CIR.0000162467.53001.6B.
Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW, Sousa AG. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation. 2005 May 10;111(18):2326-9. doi: 10.1161/01.CIR.0000164271.01172.1A. Epub 2005 Apr 25.
Newton-Cheh C, Larson MG, Corey DC, Benjamin EJ, Herbert AG, Levy D, D’Agostino RB, O’Donnell CJ. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. Heart Rhythm. 2005 Mar;2(3):277-84. doi: 10.1016/j.hrthm.2004.11.009.
Cantor WJ, Goodman SG, Cannon CP, Murphy SA, Charlesworth A, Braunwauld E, Langer A. Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial. Am Heart J. 2005 Feb;149(2):275-83. doi: 10.1016/j.ahj.2004.05.055.
Sabatine MS, McCabe CH, Gibson CM, Cannon CP. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial. Am Heart J. 2005 Feb;149(2):227-33. doi: 10.1016/j.ahj.2004.11.006.
Cannon CP, Braunwald E, McCabe CH, Grayston JT, Muhlestein B, Giugliano RP, Cairns R, Skene AM; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med. 2005 Apr 21;352(16):1646-54. doi: 10.1056/NEJMoa043528.
Wong SC, Hong MK, Ellis SG, Buchbinder M, Reisman M, DeLago A, Kellett M, Popma JJ, Russell ME, Mehran R, Moses JW, Stone GW. Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study). Am J Cardiol. 2005 May 1;95(9):1043-8. doi: 10.1016/j.amjcard.2005.01.024.
Kereiakes DJ, Kuntz RE, Mauri L, Krucoff MW. Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. J Am Coll Cardiol. 2005 Apr 19;45(8):1206-12. doi: 10.1016/j.jacc.2005.01.005.
Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O’shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005 Apr 19;45(8):1193-200. doi: 10.1016/j.jacc.2004.11.063.
Liu FF, Stone JR, Schuldt AJ, Okoshi K, Okoshi MP, Nakayama M, Ho KK, Manning WJ, Marchionni MA, Lorell BH, Morgan JP, Yan X. Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure. Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H660-6. doi: 10.1152/ajpheart.00268.2005. Epub 2005 Apr 15.
Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005 Apr 26;111(16):2042-9. doi: 10.1161/01.CIR.0000162477.70955.5F. Epub 2005 Apr 11.
Gurjeva OS, Bukhman G, Murphy S, Cannon CP. Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16. Int J Cardiol. 2005 Apr 8;100(1):101-7. doi: 10.1016/j.ijcard.2004.08.075.
Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005 Apr 15;95(8):948-54. doi: 10.1016/j.amjcard.2004.12.032.
Yang Q, Lai CQ, Parnell L, Cupples LA, Adiconis X, Zhu Y, Wilson PW, Housman DE, Shearman AM, D’Agostino RB, Ordovas JM. Genome-wide linkage analyses and candidate gene fine mapping for HDL3 cholesterol: the Framingham Study. J Lipid Res. 2005 Jul;46(7):1416-25. doi: 10.1194/jlr.M400382-JLR200. Epub 2005 Apr 1.
Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, Wiswell TE, Gadzinowski J, Hajdu J, Bernstein G, Sanchez-Luna M, Segal R, Schaber CJ, Massaro J, d’Agostino R; Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 2005 Apr;115(4):1030-8. doi: 10.1542/peds.2004-2231.
Moya FR, Gadzinowski J, Bancalari E, Salinas V, Kopelman B, Bancalari A, Kornacka MK, Merritt TA, Segal R, Schaber CJ, Tsai H, Massaro J, d’Agostino R; International Surfaxin Collaborative Study Group. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics. 2005 Apr;115(4):1018-29. doi: 10.1542/peds.2004-2183.
Fischell TA, Maheshwari A, Mirza RA, Haller S, Carter AJ, Popma JJ. Impact of frame selection on quantitative coronary angiographic analysis after coronary stenting. Catheter Cardiovasc Interv. 2005 Apr;64(4):460-7. doi: 10.1002/ccd.20344.
Fox CS, Heard-Costa NL, Vasan RS, Murabito JM, D’Agostino RB Sr, Atwood LD; Framingham Heart Study. Genomewide linkage analysis of weight change in the Framingham Heart Study. J Clin Endocrinol Metab. 2005 Jun;90(6):3197-201. doi: 10.1210/jc.2004-1752. Epub 2005 Mar 15.
Sabatine MS, Blake GJ, Drazner MH, Morrow DA, Scirica BM, Murphy SA, McCabe CH, Weintraub WS, Gibson CM, Cannon CP. Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment. Circulation. 2005 Mar 15;111(10):1217-24. doi: 10.1161/01.CIR.0000157733.50479.B9.
Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundström J, Kannel WB, Levy D, D’Agostino RB. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 2005 Mar 15;142(6):393-402. doi: 10.7326/0003-4819-142-6-200503150-00005.
Anwaruddin S, Januzzi JL Jr, Baggish AL, Lewandrowski EL, Lewandrowski KB. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol. 2005 Jan;123(1):140-5. doi: 10.1309/4bctg5ucymqfwblr.
Sonnenberg L, Pencina M, Kimokoti R, Quatromoni P, Nam BH, D’Agostino R, Meigs JB, Ordovas J, Cobain M, Millen B. Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res. 2005 Jan;13(1):153-62. doi: 10.1038/oby.2005.20.
Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E; CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005 Mar 24;352(12):1179-89. doi: 10.1056/NEJMoa050522. Epub 2005 Mar 9.
Guillozet-Bongaarts AL, Garcia-Sierra F, Reynolds MR, Horowitz PM, Fu Y, Wang T, Cahill ME, Bigio EH, Berry RW, Binder LI. Tau truncation during neurofibrillary tangle evolution in Alzheimer’s disease. Neurobiol Aging. 2005 Jul;26(7):1015-22. doi: 10.1016/j.neurobiolaging.2004.09.019. Epub 2004 Dec 16.
Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D’Agostino RB, Levy D, Vasan RS. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation. 2005 Mar 22;111(11):1370-6. doi: 10.1161/01.CIR.0000158434.69180.2D. Epub 2005 Feb 28.
Dhingra R, Ho Nam B, Benjamin EJ, Wang TJ, Larson MG, D’Agostino RB Sr, Levy D, Vasan RS. Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study. J Am Coll Cardiol. 2005 Mar 1;45(5):685-9. doi: 10.1016/j.jacc.2004.11.046.
Shvilkin A, Ho KK, Rosen MR, Josephson ME. T-vector direction differentiates postpacing from ischemic T-wave inversion in precordial leads. Circulation. 2005 Mar 1;111(8):969-74. doi: 10.1161/01.CIR.0000156463.51021.07. Epub 2005 Feb 14.
Prasad A, Stone GW, Stuckey TD, Costantini CO, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines CL, Lansky AJ, Gersh BJ. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol. 2005 Feb 15;45(4):508-14. doi: 10.1016/j.jacc.2004.10.054.
De Bartolo L, Morelli S, Lopez LC, Giorno L, Campana C, Salerno S, Rende M, Favia P, Detomaso L, Gristina R, d’Agostino R, Drioli E. Biotransformation and liver-specific functions of human hepatocytes in culture on RGD-immobilized plasma-processed membranes. Biomaterials. 2005 Jul;26(21):4432-41. doi: 10.1016/j.biomaterials.2004.11.009.
Vasan RS, D’Agostino RB Sr. Age and time need not and should not be eliminated from the coronary risk prediction models. Circulation. 2005 Feb 8;111(5):542-5. doi: 10.1161/01.CIR.0000156100.73739.B8.
Sarkozy A, Conti E, Neri C, D’Agostino R, Digilio MC, Esposito G, Toscano A, Marino B, Pizzuti A, Dallapiccola B. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet. 2005 Feb;42(2):e16. doi: 10.1136/jmg.2004.026740.
Reynolds MR, Berry RW, Binder LI. Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer’s disease. Biochemistry. 2005 Feb 8;44(5):1690-700. doi: 10.1021/bi047982v.
Gibson CM, Kirtane AJ, Boundy K, Ly H, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E; TIMI Study Group. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients. J Am Coll Cardiol. 2005 Feb 1;45(3):357-62. doi: 10.1016/j.jacc.2004.10.047.
Elias PK, Elias MF, D’Agostino RB, Sullivan LM, Wolf PA. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med. 2005 Jan-Feb;67(1):24-30. doi: 10.1097/01.psy.0000151745.67285.c2.
Ray KK, Morrow DA, Gibson CM, Murphy S, Antman EM, Braunwald E. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy. Eur Heart J. 2005 Mar;26(5):440-6. doi: 10.1093/eurheartj/ehi104. Epub 2005 Jan 26.
Ly HQ, Kirtane AJ, Buros J, Giugliano RP, Popma JJ, Antman EM, Harrington RA, Ohman EM, Gibson CM; TIMI Study Group. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction. Am J Cardiol. 2005 Feb 1;95(3):383-6. doi: 10.1016/j.amjcard.2004.09.038.
Kirtane AJ, Kosmidou I, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Braunwald E, Gibson CM; TIMI Study Group. Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy. Am J Cardiol. 2005 Feb 1;95(3):337-42. doi: 10.1016/j.amjcard.2004.09.030.
Mauri L, Orav EJ, O’Malley AJ, Moses JW, Leon MB, Holmes DR Jr, Teirstein PS, Schofer J, Breithardt G, Cutlip DE, Kereiakes DJ, Shi C, Firth BG, Donohoe DJ, Kuntz RE. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation. 2005 Jan 25;111(3):321-7. doi: 10.1161/01.CIR.0000153356.72810.97. Epub 2005 Jan 17.
Baron SJ, Li J, Russell RR 3rd, Neumann D, Miller EJ, Tuerk R, Wallimann T, Hurley RL, Witters LA, Young LH. Dual mechanisms regulating AMPK kinase action in the ischemic heart. Circ Res. 2005 Feb 18;96(3):337-45. doi: 10.1161/01.RES.0000155723.53868.d2. Epub 2005 Jan 13.
DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, Beiser A, D’Agostino R, Wolf PA. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging. 2005 Apr;26(4):491-510. doi: 10.1016/j.neurobiolaging.2004.05.004.
Kirtane AJ, Martinezclark P, Rahman AM, Ray KK, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Roe MT, Harrington RA, Ohman EM, Braunwald E, Gibson CM. Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005 Jan 18;45(2):321-3. doi: 10.1016/j.jacc.2004.10.018.
Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR Jr. Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol. 2005 Jan 18;45(2):198-203. doi: 10.1016/j.jacc.2004.05.089.
Sarkozy A, Conti E, D’Agostino R, Digilio MC, Formigari R, Picchio F, Marino B, Pizzuti A, Dallapiccola B. ZFPM2/FOG2 and HEY2 genes analysis in nonsyndromic tricuspid atresia. Am J Med Genet A. 2005 Feb 15;133A(1):68-70. doi: 10.1002/ajmg.a.30534.
Kashani A, Gibson CM, Murphy SA, Sabatine MS, Morrow DA, Antman EM, Giugliano RP. Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction. Am J Cardiol. 2005 Jan 15;95(2):228-33. doi: 10.1016/j.amjcard.2004.08.092.
Kirtane AJ, Weisbord A, Karmpaliotis D, Murphy SA, Giugliano RP, Cannon CP, Antman EM, Ohman EM, Roe MT, Braunwald E, Gibson CM; TIMI Study Group. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction. Am J Cardiol. 2005 Jan 15;95(2):224-7. doi: 10.1016/j.amjcard.2004.09.007.
Giugliano GR, Kuntz RE, Popma JJ, Cutlip DE, Baim DS; Saphenous Vein Graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device. Am J Cardiol. 2005 Jan 15;95(2):173-7. doi: 10.1016/j.amjcard.2004.08.090.
Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005 Jan 6;352(1):20-8. doi: 10.1056/NEJMoa042378.
Dokainish H, Pillai M, Murphy SA, DiBattiste PM, Schweiger MJ, Lotfi A, Morrow DA, Cannon CP, Braunwald E, Lakkis N; TACTICS-TIMI-18 Investigators. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol. 2005 Jan 4;45(1):19-24. doi: 10.1016/j.jacc.2004.09.056.
Chauhan MS, Ho KK, Baim DS, Kuntz RE, Cutlip DE. Effect of gender on in-hospital and one-year outcomes after contemporary coronary artery stenting. Am J Cardiol. 2005 Jan 1;95(1):101-4. doi: 10.1016/j.amjcard.2004.08.070.
Sketch MH Jr, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ; Driver investigators. Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. Am J Cardiol. 2005 Jan 1;95(1):8-12. doi: 10.1016/j.amjcard.2004.08.055.
Wu B, Elmariah S, Kaplan FS, Cheng G, Mohler ER 3rd. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):592-7. doi: 10.1161/01.ATV.0000154278.01871.64. Epub 2004 Dec 23.
Sundström J, Sullivan L, D’Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005 Jan;45(1):28-33. doi: 10.1161/01.HYP.0000150784.92944.9a. Epub 2004 Nov 29.
Turchin A, Wiebe DA, Seely EW, Graham T, Longo W, Soiffer R. Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver. Bone Marrow Transplant. 2005 Jan;35(1):85-9. doi: 10.1038/sj.bmt.1704739.